Next stop: Beacon Hill.
Governor Maura Healey’s long-awaited plan to double down on state funding for the biotech and medical technology sector came into focus Thursday with the announcement she’ll seek $1 billion over the next decade to reauthorize the state’s 16-year-old life sciences initiative.
advertisement
But lawmakers so far are noncommittal on funding the plan. The proposal — dubbed “Life Sciences 3.0″ — is part of a larger economic development bill the Healey administration is expected to file soon. Several expressed support for an industry in which Massachusetts is a leader, but also noted the spending request comes at a time of competing priorities.
Get unlimited access to award-winning journalism and exclusive events.
Subscribe Log In
Previous article：
Health tech investors get more selective as pandemic boom fades
Next article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： DIEP, the 'gold standard' of breast reconstruction, is under threat
